The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma.

Zhixian WuHongwei ChengJie LiuShuaishuai ZhangMinda ZhangFangzhou LiuYinghui LiQian HuangYi JiangShaohua ChenLizhi LvDongliang LiJin-Zhang Zeng

Published in: Journal of hepatocellular carcinoma (2022)

STC2 is upregulated in both tumor and serum of HCC patients, and its overexpression promotes HCC via AKT pathway. STC2 possesses a diagnostic significance and may serve as an auxiliary biomarker of AFP for detecting early HCC.

Keyphrases

end stage renal disease
cell proliferation
newly diagnosed
chronic kidney disease
transcription factor
signaling pathway
patient reported
climate change